Blessme · Anti-Panic & Anticonvulsants

Clonazepam MD Tablets - DELOTRIL (2 mg)

DELOTRIL-2 is a maximum-strength Clonazepam Mouth Dissolving Tablets IP 2 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Formulated with fast-melt oral disintegration technology, DELOTRIL-2 provides rapid sublingual dissolution without water, delivering maximum-potency anticonvulsant and anti-panic stabilization for tertiary hospitals and PCD franchise partners across India.

Fast-Melt MD Formulation
Schedule H Prescription
Pan-India Supply
DELOTRIL-2 Clonazepam MD Tablets IP 2 mg pack by Blessme - Dellwich Lifescience LLP
Product Specifications

About Clonazepam MD 2 mg
(DELOTRIL-2)

Detailed pharmaceutical specifications, active API monograph compliance, fast-melt characteristics, and packaging details for DELOTRIL-2.

Blessme · Anti-Panic / Anticonvulsants

Clonazepam MD 2 mg - DELOTRIL

Clonazepam Mouth Dissolving Tablets IP 2 mg (DELOTRIL-2) is a maximum clinical strength benzodiazepine oral formulation engineered to dissolve rapidly on the tongue without water. Provides robust control for refractory epilepsy, severe status-related seizure management, and extreme panic crises under expert medical supervision.

Fast Mouth-Dissolving Technology (No Water Needed) Maximum Potency 2 mg Clinical StrengthEssential in Refractory & Lennox-Gastaut SeizuresRapid Sublingual & Mucosal Absorption Strict Indian Pharmacopoeia Quality Standards
Product Brand Name
DELOTRIL-2
Active Pharmaceutical Ingredient
Clonazepam IP (2 mg)Verified IP
Dosage Formulation
Mouth Dissolving Tablet (MD / ODT)
Therapeutic Class
High-Potency Benzodiazepine / Anticonvulsant / Anti-Panic / Anxiolytic
Strength
2 mg per tablet
Standard Packaging
5x4x10 (200 Tablets) Blister Pack
Regulatory Category
Schedule H Prescription Drug
Marketing Division
Blessme · Neuro & Psychiatric Products
Marketing & Distribution Company
Dellwich Lifescience LLP, Ahmedabad, Gujarat
Storage Condition
Store protected from light and moisture at a temperature below 25°C
Quality Standard
Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
Country of Origin
India
Clinical & Commercial Monograph

Clonazepam MD Tablet 2 mg & DELOTRIL
Complete Medical & Supply Guide

Comprehensive clinical and commercial guide on Clonazepam Mouth Dissolving Tablets IP 2 mg, marketed as DELOTRIL-2 by Blessme (Dellwich Lifescience LLP). Features receptor neurochemistry, refractory epilepsy management, comparative dosing, and B2B pharmaceutical distribution across India.

What is Clonazepam MD Tablet 2 mg (DELOTRIL-2)?

Clonazepam MD tablet 2 mg is the highest standard oral clinical strength of Clonazepam IP formulated in an advanced orally disintegrating matrix. It is prescribed when maximum antiepileptic potency and deep GABAergic inhibition are required to suppress refractory seizure activity or incapacitating panic crises.

During neurological seizure clusters or post-ictal states, patients may suffer from impaired swallowing or motor coordination. DELOTRIL-2 dissolves smoothly on the tongue within 30 seconds upon contact with saliva, initiating fast mucosal uptake and clinical tranquilization without liquid administration.

Clinical Uses & Indications of Clonazepam MD 2 mg

Clonazepam MD tablet uses for the 2 mg strength focus on complex, high-severity neurological and psychiatric conditions:

  • Refractory Epilepsy Syndromes: Crucial oral adjunctive maintenance in Lennox-Gastaut syndrome, akinetic seizures, and intractable myoclonic epilepsies.
  • Severe Agoraphobia & Panic Crises: Rapid stabilization of severe panic disorder resistant to standard 0.5 mg and 1 mg therapy.
  • Seizure Cluster Prevention: Rapid-onset oral suppression to prevent status epilepticus recurrence following acute emergency control.
  • Severe Catatonia & Inpatient Agitation: Rapid-acting benzodiazepine therapy in acute neuropsychiatric hospital admissions.
  • Severe Sleep & Motor Parasomnias: Off-label specialist management of severe REM sleep behavior disorder.

Neurochemical Mechanism of Action: Potent GABA_A Receptor Modulation

Clonazepam 2 mg acts as a high-potency positive allosteric modulator on the GABAA receptor complex in the central nervous system. By enhancing the binding of gamma-aminobutyric acid (GABA), it increases the opening frequency of chloride ion channels, causing significant hyperpolarization of neuronal membranes.

This mechanism suppresses paroxysmal electrical firing in the epileptogenic focus, subcortical pacemakers, and thalamocortical networks. The Mouth Dissolving (MD) formulation allows a portion of the drug to be absorbed sublingually and buccally, facilitating rapid systemic entry and symptom relief during intense clinical emergencies.

Clinical Comparison Across the DELOTRIL Range

The DELOTRIL portfolio provides tiered therapeutic options for individual patient requirements:

  • DELOTRIL-0.25 (0.25 mg): Starting micro-dose for initial acclimatization, mild situational anxiety, and elderly patients.
  • DELOTRIL-0.5 (0.5 mg): Standard first-line maintenance dose for established panic disorder and generalized anxiety.
  • DELOTRIL-1 (1 mg): High-potency clinical dose for severe panic attacks, refractory anxiety, and epileptic seizure control.
  • DELOTRIL-2 (2 mg): Maximum-strength formulation for refractory epilepsy syndromes, Lennox-Gastaut, and acute psychiatric emergencies.

Dosage Guidelines & Administration Method

DELOTRIL-2 must be administered under strict medical supervision:

  • Administration: Place the tablet on the tongue until it dissolves completely in saliva, then swallow. No water is required.
  • Epileptic Seizures: Daily dosage may range from 1.5 mg up to 20 mg divided into 3 to 4 doses, carefully titrated by the neurologist.
  • Severe Panic Disorder: Generally restricted to patients previously stabilized on 1 mg who require stepped-up therapeutic control.
  • Tapering Protocol: When discontinuing, reduce dosage very slowly over weeks to prevent severe withdrawal seizures and autonomic crisis.

Clonazepam MD Tablet Brands in India & Sourcing DELOTRIL

Among established brands in India (Clonafit, Zapiz, Epitril), DELOTRIL-2 by Blessme has earned clinical trust for its reliability and commercial value:

  • Fast Salivary Disintegration: Melts completely within 30 seconds with a pleasant oral feel.
  • Moisture-Resistant Blister Strips: Protects tablet hardness against ambient humidity and degradation.
  • Manufacturer-Direct Commercials: Competitive B2B rates and high profit margins for PCD franchise distributors.
  • Complete Regulatory Dossiers: Authenticated COA, MSDS, and stability records provided with every batch.

Side Effects, Precautions & Patient Safety

Essential clinical warnings for healthcare professionals and patients:

  • Expected Reactions: Pronounced drowsiness, motor ataxia, dizziness, and cognitive slowing.
  • Avoid Concurrent Depressants: Never combine with alcohol, opioids, or sedatives due to lethal respiratory suppression risks.
  • Dependence Risk: High potency increases the risk of physical and psychological dependence; duration must be restricted to clinical necessity.
  • Contraindications: Severe respiratory insufficiency, sleep apnoea, myasthenia gravis, and severe liver failure.

Critical Safety Warning - Schedule H Controlled Psychotropic Substance

Clonazepam 2 mg is a maximum-strength benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use requires careful clinical monitoring. DELOTRIL-2 is supplied strictly against a valid medical prescription from a registered medical practitioner.

Quality & Production

Pharmaceutical Quality Assurance & Compliance

DELOTRIL-2 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.

01 / FAST-MELT MATRIX

Sub-30 Second Disintegration

Formulated with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.

02 / HIGH-BARRIER FOIL

Moisture-Proof Blister Sealing

Encased in 5x4x10 protective blister cavities that insulate the hygroscopic fast-melt tablet from ambient atmospheric moisture, heat, and physical crumbling.

03 / ANALYTICAL TESTING

COA & Content Uniformity

Strict pharmacopoeial monograph assays confirm precise 2 mg Clonazepam IP content, rapid disintegration limits, and dissolution conformity batch after batch.

04 / PRODUCTION STANDARDS

WHO-GMP & Schedule M

Produced in state-of-the-art clean-room compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP) with automated environmental controls.

Clinical Profile & Precautions

Approved Indications & Regulatory Guidelines

As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.

Prescription-Only Schedule H Medication Notice

DELOTRIL-2 contains Clonazepam IP 2 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.

Clinical Indications Profile

Approved neurological and psychiatric indications for Clonazepam MD 2 mg (DELOTRIL-2):

  • Refractory Epilepsies: Potent oral maintenance in Lennox-Gastaut syndrome, myoclonic seizures, and absence seizures.
  • Severe Incapacitating Panic Disorder: Rapid containment of debilitating agoraphobia and panic paroxysms.
  • Seizure Cluster Suppression: Oral maintenance to prevent status epilepticus recurrence.
  • Inpatient Psychiatric Sedation: Management of severe catatonia and violent psychomotor agitation.
  • REM Sleep Behavior Disorder: High-efficacy nocturnal motor suppression under sleep specialist care.

Pharmacology & Clinical Precautions

Key pharmacokinetic parameters and patient monitoring guidelines:

  • Mechanism: High-affinity positive allosteric modulation of GABA_A chloride channel conductance.
  • Synergistic Depression: Severe respiratory risk if co-administered with alcohol, opioids, or sedatives.
  • Hepatic Clearance: Extensively metabolized in the liver to 7-amino-clonazepam; dose reduction is advised in hepatic dysfunction.
  • Pregnancy Category D: Potential risks of fetal harm; avoid during pregnancy and lactation unless strictly essential.
Manufacturing & Marketing
Dellwich Lifescience LLP
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience

Trusted Neuro & Psychiatric Pharmaceutical Manufacturer in Ahmedabad, Gujarat

Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-2 (Clonazepam MD Tablets IP 2 mg).

We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.

Commercial Partnerships

DELOTRIL-2 Supply &
Pharmaceutical Distribution

Whether you are seeking DELOTRIL-2 (Clonazepam MD Tablets IP 2 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.

Monopoly PCD Franchise

Secure exclusive district-level distribution rights for DELOTRIL-2 and the entire Blessme Neuro portfolio with promotional visual aids, doctor samples, and attractive trade margins.

Third-Party Manufacturing

Contract manufacturing solutions for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.

Hospital & Institutional Supply

Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.

Blessme · DELOTRIL-2

Why Choose DELOTRIL-2 (Clonazepam MD 2 mg)?

When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-2 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.

WHO-GMP Certified Purity

Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.

High-Barrier Blister Packaging

Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.

Pan-India Dispatch from Ahmedabad

Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.

Monopoly PCD Franchise Rights

Exclusive district-level franchise rights for DELOTRIL-2 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.

Comprehensive Regulatory Dossiers

Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.

Direct Manufacturer Support

Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.

Common Questions

Frequently Asked Questions about DELOTRIL-2

Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 2 mg.

What is Clonazepam MD tablet 2 mg and what is DELOTRIL-2?

Clonazepam MD tablet 2 mg (marketed under the brand name DELOTRIL-2 by Blessme division of Dellwich Lifescience LLP) is a maximum clinical strength orally disintegrating benzodiazepine formulation. Each tablet contains Clonazepam IP 2 mg, engineered to dissolve rapidly on the tongue without water, providing fast sublingual and mucosal absorption for refractory epileptic seizures, severe agoraphobia, and acute psychiatric crises.

What are the primary clinical indications of Clonazepam MD 2 mg?

DELOTRIL-2 is indicated in specialized neurology and psychiatry for: (1) refractory epilepsy including akinetic, myoclonic, and atypical absence seizures; (2) Lennox-Gastaut syndrome in children and adults; (3) severe, incapacitating panic disorder and agoraphobia unresponsive to lower strengths; and (4) acute psychiatric agitation or catatonia under specialist medical oversight.

Why is the Mouth Dissolving (MD) technology crucial for DELOTRIL-2?

In seizure disorders and severe panic crises, patients may experience impaired motor control, tremors, or post-ictal drowsiness that make swallowing tablets with water hazardous. DELOTRIL-2 melts on the tongue in under 30 seconds upon contact with saliva, allowing prompt and safe administration without choking hazards.

What is the difference between DELOTRIL-1 and DELOTRIL-2?

DELOTRIL-1 contains 1 mg Clonazepam IP, used for moderate-to-severe panic disorder and standard epilepsy regimens. DELOTRIL-2 contains 2 mg Clonazepam IP, providing double the therapeutic potency for refractory seizure clusters, status-related maintenance, and severe psychiatric agitation requiring higher dosage thresholds.

How does Clonazepam 2 mg work in the central nervous system?

Clonazepam 2 mg acts as a high-potency positive allosteric modulator on post-synaptic GABA_A receptor-chloride ion channel complexes throughout the brain. By enhancing the inhibitory action of gamma-aminobutyric acid, it stimulates massive inward chloride flux, deeply hyperpolarizing neuronal membranes and abruptly extinguishing epileptogenic foci and acute panic discharge circuits.

Can DELOTRIL-2 be purchased over-the-counter without a prescription?

No. Clonazepam 2 mg is strictly categorized as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-2 can only be dispensed against a valid prescription issued by a registered medical practitioner.

What packaging and strip configurations are available for DELOTRIL-2?

DELOTRIL-2 is packaged in high-barrier 5x4x10 blister strips (200 tablets per box) manufactured with moisture-impermeable foils that protect the delicate fast-melt matrix from tropical ambient humidity and transit vibration.

Who manufactures and markets DELOTRIL-2 in Ahmedabad, India?

DELOTRIL-2 is manufactured under WHO-GMP compliance and marketed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.

Is PCD pharma franchise available for DELOTRIL-2 across India?

Yes. Dellwich Lifescience LLP provides exclusive district monopoly PCD pharma franchise opportunities for DELOTRIL-2 and the complete Blessme Neuro and Psychiatric range, complete with promotional visual aids, product catalogs, MR bags, and prompt delivery.

How should DELOTRIL-2 be administered and what is the typical dosage?

Place the tablet directly on the tongue until it dissolves in saliva, then swallow. No water is needed. In epilepsy, adult dosage is carefully titrated from lower doses up to 2 mg taken 2 to 3 times daily, not exceeding maximum physician-prescribed limits. Discontinuation must be carried out by slow, gradual tapering.

What are the common side effects of Clonazepam MD 2 mg tablet?

Due to its high potency, significant sedation, motor clumsiness, ataxia, and muscular relaxation are expected. Patients must not drive or operate machinery. Chronic usage leads to tolerance and physical dependence, mandating strict medical supervision.

What is the price of Clonazepam 2 mg MD tablet in India?

DELOTRIL-2 is priced competitively with high B2B distributor margins. For official trade rate lists, PCD franchise terms, and institutional hospital supply quotes, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].

Does Dellwich Lifescience provide third-party contract manufacturing for Clonazepam MD 2 mg?

Yes. Dellwich Lifescience LLP offers third-party and loan license manufacturing for Clonazepam MD tablets across 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths in WHO-GMP certified facilities with complete stability validation.

Does DELOTRIL-2 come with an authenticated Certificate of Analysis (COA)?

Yes. Every batch of DELOTRIL-2 is accompanied by an authenticated Certificate of Analysis (COA), disintegration assay records, active IP testing, and Material Safety Data Sheet (MSDS).

Direct Pharmaceutical Enquiry

Need Verified Information or Bulk Supply of DELOTRIL-2?

Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.

Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs

Enquire About DELOTRIL-2

Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 2 mg.

🔒 Schedule H Drug notice: Product supplied strictly against valid drug licence and regulatory compliance.

Explore Further

Discover other specialized neuro-psychiatric treatments, PCD franchise categories, and hospital supply options from Dellwich Lifescience LLP.